LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 220 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $157,470 | -19.2% | 2,628 | -2.8% | 0.00% | 0.0% |
Q2 2023 | $194,958 | -4.4% | 2,704 | -2.5% | 0.00% | 0.0% |
Q1 2023 | $203,908 | +66.3% | 2,772 | +51.1% | 0.00% | 0.0% |
Q4 2022 | $122,578 | -39.0% | 1,835 | -21.3% | 0.00% | 0.0% |
Q3 2022 | $201,000 | -3.4% | 2,331 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $208,000 | -21.2% | 2,331 | -0.7% | 0.00% | 0.0% |
Q1 2022 | $264,000 | -20.2% | 2,348 | +9.4% | 0.00% | -50.0% |
Q4 2021 | $331,000 | +40.3% | 2,146 | +26.8% | 0.00% | +100.0% |
Q3 2021 | $236,000 | +6.3% | 1,692 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $222,000 | -14.0% | 1,692 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $258,000 | +16.7% | 1,692 | -23.7% | 0.00% | +100.0% |
Q4 2020 | $221,000 | +30.8% | 2,218 | +25.4% | 0.00% | 0.0% |
Q3 2020 | $169,000 | -14.6% | 1,769 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $198,000 | +92.2% | 1,769 | +25.2% | 0.00% | +100.0% |
Q1 2020 | $103,000 | -29.9% | 1,413 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $147,000 | +4.3% | 1,413 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $141,000 | -12.4% | 1,413 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $161,000 | -9.6% | 1,413 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $178,000 | -7.8% | 1,413 | -0.4% | 0.00% | 0.0% |
Q4 2018 | $193,000 | -50.5% | 1,419 | 0.0% | 0.00% | -33.3% |
Q3 2018 | $390,000 | +41.8% | 1,419 | +7.0% | 0.00% | +50.0% |
Q2 2018 | $275,000 | +51.1% | 1,326 | +20.4% | 0.00% | 0.0% |
Q1 2018 | $182,000 | +20.5% | 1,101 | 0.0% | 0.00% | +100.0% |
Q4 2017 | $151,000 | +49.5% | 1,101 | +48.4% | 0.00% | 0.0% |
Q3 2017 | $101,000 | +12.2% | 742 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $90,000 | +32.4% | 742 | +15.2% | 0.00% | 0.0% |
Q1 2017 | $68,000 | +4.6% | 644 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $65,000 | -1.5% | 644 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $66,000 | -2.9% | 644 | +12.8% | 0.00% | 0.0% |
Q2 2016 | $68,000 | +11.5% | 571 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $61,000 | -1.6% | 571 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $62,000 | +313.3% | 571 | +219.0% | 0.00% | – |
Q3 2015 | $15,000 | +50.0% | 179 | +84.5% | 0.00% | – |
Q2 2015 | $10,000 | +42.9% | 97 | 0.0% | 0.00% | – |
Q1 2015 | $7,000 | – | 97 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
RK Capital | 174,283 | $8,190,000 | 1.67% |
Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |